Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
Running, not enrolling · Phase 2 · Has a placebo group
Conditions studied: Obesity
In brief
The primary objective of this study is to determine the effects of ribupatide administered by subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.
Key facts
- Study ID
- NCT07458269
- Run by
- Kailera
- People needed
- 264
- Starts
- 2026-03-04
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-07-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Kailera Clinical Site — Mesa, Arizona, United States
- Kailera Clinical Site — Sun City West, Arizona, United States
- Kailera Clinical Site — Irvine, California, United States
- Kailera Clinical Site — Lake Forest, California, United States
- Kailera Clinical Site — Lomita, California, United States
- Kailera Clinical Site — Long Beach, California, United States
- Kailera Clinical Site — Montclair, California, United States
- Kailera Clinical Site — Rolling Hills Estates, California, United States
- Kailera Clinical Site — San Diego, California, United States
- Kailera Clinical Site — Santa Ana, California, United States
- Kailera Clinical Site — Van Nuys, California, United States
- Kailera Clinical Site — DeLand, Florida, United States
- Kailera Clinical Site — Orlando, Florida, United States
- Kailera Clinical Site — Orlando, Florida, United States
- Kailera Clinical Site — The Villages, Florida, United States
- Kailera Clinical Site — Decatur, Georgia, United States
- Kailera Clinical Site — Woodstock, Georgia, United States
- Kailera Clinical Site — Morton, Illinois, United States
- Kailera Clinical Site — Indianapolis, Indiana, United States
- Kailera Clinical Site — Louisville, Kentucky, United States
- Kailera Clinical Site — Rockville, Maryland, United States
- Kailera Clinical Site — St Louis, Missouri, United States
- Kailera Clinical Site — Lincoln, Nebraska, United States
- Kailera Clinical Site — Omaha, Nebraska, United States
- Kailera Clinical Site — East Syracuse, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.